Last updated: 9 months ago
Mainz Biomed's 6-K Report: Financial Recovery & Nasdaq Compliance Insights
Explore Mainz Biomed N.V.'s January 2025 Form 6-K report detailing financial recovery actions and Nasdaq compliance status. Key insights on stockholders' equity and future implications.